Clinical trials
Phase 3 Kidney Diseases trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 5 |
| Recruiting | 4 |
| Completed | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Bayer | 2 |
| Amicus Therapeutics | 1 |
| AstraZeneca | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Dimerix Bioscience Pty Ltd | 1 |
| Eli Lilly and Company | 1 |
| Kyowa Kirin Co., Ltd. | 1 |
| Pfizer | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 13 |
| Renal Insufficiency, Chronic | 5 |
| Urologic Diseases | 4 |
| Diabetic Nephropathies | 3 |
| Glomerulonephritis | 3 |
| Glomerulonephritis, IGA | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Carcinoma, Renal Cell | 1 |
| Diabetes Mellitus | 1 |
| Fabry Disease | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.